Molly Henderson
Chief Financial Officer
CFO
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Phathom Pharmaceuticals, Inc. (PHAT) | Chief Financial and Business Officer | $515,000 | $1,424,212 |
| 2023 | Phathom Pharmaceuticals, Inc. (PHAT) | Chief Financial and Business Officer | $500,000 | $1,873,793 |
| 2022 | Phathom Pharmaceuticals, Inc. (PHAT) | Chief Financial and Business Officer | $356,615 | $2,648,537 |
Executive changes
Earnings-call appearances
-
Phathom Pharmaceuticals, Inc. Q1 FY2025 Earnings Call2025-05-01
Phathom Pharmaceuticals, Inc. (PHAT)
-
Phathom Pharmaceuticals, Inc. Q4 FY2024 Earnings Call2025-03-06
Phathom Pharmaceuticals, Inc. (PHAT)
-
Phathom Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-11-07
Phathom Pharmaceuticals, Inc. (PHAT)
-
Phathom Pharmaceuticals, Inc. Q2 FY2024 Earnings Call2024-08-08
Phathom Pharmaceuticals, Inc. (PHAT)
-
Phathom Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-05-09
Phathom Pharmaceuticals, Inc. (PHAT)
-
Phathom Pharmaceuticals, Inc. Q4 FY2023 Earnings Call2024-03-07
Phathom Pharmaceuticals, Inc. (PHAT)